Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Jazz Pharma Plc
(NQ:
JAZZ
)
122.59
-0.55 (-0.45%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jazz Pharma Plc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
7 Biotech Stocks to Boost Your Portfolio to Peak Health
June 26, 2024
With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas.
Via
InvestorPlace
3 Cannabis Stocks That Could Make Your Grandchildren Rich
June 25, 2024
These cannabis stocks offer long-term growth potential anchored by solid operational models and diversified revenue streams today.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?
June 20, 2024
Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no significant improvements over placebo.
Via
Benzinga
Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure
June 20, 2024
The companies are working on treatments for essential tremor, a tricky indication.
Via
Investor's Business Daily
3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition
June 14, 2024
These blue-chip stocks offer stability, sustainable growth and operational models less prone to wider economic fluctuations.
Via
InvestorPlace
Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals
June 05, 2024
Via
Benzinga
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
May 02, 2024
Via
Benzinga
Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
April 10, 2024
Via
Benzinga
The Analyst Landscape: 12 Takes On Jazz Pharmaceuticals
March 20, 2024
Via
Benzinga
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
June 05, 2024
Via
Benzinga
7 Overlooked Stocks Offering Long-Term Stability From the Shadows
June 03, 2024
These overlooked stocks offer price appreciation, income, and more while diversifying across sectors and company sizes.
Via
InvestorPlace
3 Cannabis Stocks to Buy Now: May 2024
May 26, 2024
These cannabis stocks to buy offer the best odds at capturing long-term upside from current rescheduling initiatives.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
7 Blue-Chip Stocks to Buy Now: May 2024
May 23, 2024
These blue-chip stocks to buy offer long-term price appreciation opportunities reinforced with undeniable stock stability.
Via
InvestorPlace
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Demystifying Jazz Pharmaceuticals: Insights From 4 Analyst Reviews
February 29, 2024
Via
Benzinga
3 Cheap Blue-Chip Stocks to Buy Now: May 2024
May 17, 2024
If stock market speculation isn't quite working in your favor, these cheap blue-chip stocks may be the boost your portfolio needs.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 15, 2024
Via
Benzinga
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
May 14, 2024
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
May 09, 2024
Ignite your portfolio with these seven sizzling cannabis stocks. From industry leaders to innovative upstarts.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
May 08, 2024
These top cannabis stocks by revenue are among the world's best sellers, making them prime investment opportunities to capture legal changes.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
May 01, 2024
JAZZ stock results show that Jazz Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $300 Right Now
April 24, 2024
A modest amount of money can go a long way on Wall Street when it's put to work in time-tested businesses with well-defined catalysts.
Via
The Motley Fool
How To Make Your Cannabis Business More Attractive For Investors In 2024: Advice On Financial Health & Innovation
March 25, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
HC Wainwright & Co. Maintains Buy Rating for Jazz Pharmaceuticals: Here's What You Need To Know
March 14, 2024
Via
Benzinga
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via
InvestorPlace
Time Is Still The Enemy, Says Mom Who Moved Mountains For Her Epileptic Daughter & Still Advocates For Millions Of CBD Users
March 12, 2024
Via
Benzinga
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
February 26, 2024
Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.
Via
InvestorPlace
4 Exhilarating Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
February 24, 2024
The Nasdaq Composite is the only major stock index that hasn't put the 2022 bear market in the rearview mirror. For patient investors, it means bargains still abound.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
3 Cannabis Stocks That Could Be Multibaggers in the Making: February Edition
February 20, 2024
Don’t miss out, as the following cannabis stocks are severely undervalued and are set to increase sales and make huge profits in 2024.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
The Queen Of Marijuana Investing Used Psychology To Launch Her Successful Cannabis Investment Fund
February 14, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.